← Back to front page
United States · Platforms & data · MarketBeat

Guggenheim Has Lowered Expectations for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price

Published by MarketBeat · United States 46 min ago
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Guggenheim decreased their target price on shares of Zevra Therapeutics from $23.00 to $18.00 and set a "buy" rating on the stock in a research note on Monday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading